alexa Abstract | A Review on Alzheimer Disease -its Treatment, Future Prospects and the Role of Juglans Regia in Alzheimer s Disease Based on Pathogenetic Research

Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access


The diagnosis of the Alzheimer Disease if rendered accurately today and in the foreseeable future, comes with it a disease course that is inalterable and with no hope of cure After the expansion of the molecular technology and with more than 100 years of identification of hallmark lesions of AD still there is absence of, or fundamentally erraneous understanding of AD pathogenesis. Hence there is absence of disease modifying therapy of AD. We are compelled to accept that modern science has provided a catalog of downstream changes in AD. These changes include: Amyloidosis; tau phosphorylation; oxidative stress including RNA modification and heavy metal toxicity; neurotrophic and neurogeneration failure; disordered energy metabolism; synaptic alteration; and autophagy. In this review we examine this aspect in the light of available evidences present in the literature. Furthermore pathology and pathophysiology of AD based on the recent observations is also described. A critical analysis of possible ABP transport across BBB is presented; animal models of AD are given in brief. Furthermore a new role of nano drug delivery to treat the AD is also discussed. Over 35000 plant species are currently used for medicinal purposes around the world. These plant contain more than 4000 flavanoid structures, terpenes, alkaloids, etc and provide numerous health benefits including anti-inflammatory, anti-oxidant, anti neoplastic, anti diabetic. Can we Identify the herbal extracts that affect AD pathomechanism, highlighting interaction of A β, mitochondrial anti-oxidant mechanism, inflammatory pathway, and cholinergic and glutaminergic function in pre synaptic and post synaptic neuron.This is a big question. Also Is Juglans regia (walnut) one such alternative?

To read the full article Peer-reviewed Article PDF image

Author(s): Ashna Kohli, Preeti Kothiyal


Alzheimer’s disease, amyloidosis, BBB, juglans regia, nano drug delivery, tau phosphorylation, Alzheimer Disease

Recommended Journals

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version